GlassScriptPhysician profile
Elsie Koh
NPI 1679548234
$149,706.25
in general payments reported to CMS, 2019-2025
27 companies · $33K in 2025
The $33K reported for 2025 was more than what 95% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32K · 2020: $16K · 2021: $18K · 2022: $11K · 2023: $10K · 2024: $31K · 2025: $33K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $70K · Food and Beverage: $2,539 · Travel and Lodging: $1,545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $70,000.00 |
| Food and Beverage | $2,538.55 |
| Travel and Lodging | $1,544.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $95,786.05 | 2020-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Medtronic Vascular, INC. | $30,994.97 | 2019-2020 | |
| Avenu Medical INC. | $8,207.23 | 2019-2020 | |
| Fresenius USA Marketing, INC. | $3,860.65 | 2020-2021 | |
| Medtronic, INC. | $3,684.73 | 2021-2025 | Inceptiv, Intellis Adaptivestim |
| Terumo Medical Corporation | $1,138.89 | 2021 | |
| Bard Peripheral Vascular, INC. | $1,119.19 | 2021-2025 | Venovo, Venclose Maven Catheter |
| Fresenius USA INC. | $1,000.00 | 2020 | |
| Cardiovascular Systems INC. | $873.70 | 2020-2023 | Diamondback Peripheral |
| Philips North America LLC | $555.34 | 2020-2023 | |
| Globus Medical, INC. | $554.86 | 2025 | Senza |
| Shockwave Medical, INC | $400.28 | 2025 | |
| Boston Scientific Corporation | $314.99 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $231.75 | 2022-2023 | Xarelto |
| Cordis US Corp. | $178.23 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Veryan Medical Incorporated | $138.86 | 2021-2022 | |
| 4web, INC. | $119.05 | 2025 | Spine Truss System |
| Nevro Corp. | $117.70 | 2024 | Senza |
| Vasorum USA INC. | $97.46 | 2024 | Celt Acd |
| Covidien LP | $62.03 | 2019 | |
| Tactile Systems Technology INC | $58.12 | 2023-2024 | Entre Plus, Flexitouch Plus |
| Advanced Oxygen Therapy INC. | $46.69 | 2024 | Topical Oxygen Chamber For Extremities |
| Cardinal Health 200 LLC | $46.27 | 2020-2021 | |
| Paratek Pharmaceuticals, INC. | $39.68 | 2024-2025 | Nuzyra |
| Biotronik INC. | $30.90 | 2022 | |
| Abbott Laboratories | $29.83 | 2025 | Esprit |
| Smith+Nephew, INC. | $18.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$200,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elsie Koh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.